ELISA Kit for Anti-Actin Antibody (Anti-ACTIN) Homo sapiens (Human) Antibody ELISA

Add to Cart Distributors
Overview
Properties
Share your citation Upload your experimental result Review Leave a message
Loading...

Share a new citation as an author

Upload your experimental result

Review

Please attach serial No. on instruction manual

Contact us

Please fill in the blank.

Name*
Organization
Address
E-mail address*
Telephone
Inquiry*
Verification code* CheckCode
  • ELISA Kit for Anti-Actin Antibody (Anti-ACTIN) Packages (Simulation)
  • ELISA Kit for Anti-Actin Antibody (Anti-ACTIN) Packages (Simulation)
  • ELISA Kit for Anti-Actin Antibody (Anti-ACTIN) Results demonstration
  • AES097Hu.jpg Typical Standard Curve
  • Certificate ISO9001: 2008, ISO13485: 2003 Registered

Recovery

Matrices listed below were spiked with certain level of Anti-Actin Antibody (Anti-ACTIN) and the recovery rates were calculated by comparing the measured value to the expected amount of Anti-Actin Antibody (Anti-ACTIN) in samples.

Matrix Recovery range (%) Average(%)
serum(n=5) 82-92 85
EDTA plasma(n=5) 95-105 98
heparin plasma(n=5) 79-99 95

Precision

Intra-assay Precision (Precision within an assay): 3 samples with low, middle and high level Anti-Actin Antibody (Anti-ACTIN) were tested 20 times on one plate, respectively.
Inter-assay Precision (Precision between assays): 3 samples with low, middle and high level Anti-Actin Antibody (Anti-ACTIN) were tested on 3 different plates, 8 replicates in each plate.
CV(%) = SD/meanX100
Intra-Assay: CV<10%
Inter-Assay: CV<12%

Linearity

The linearity of the kit was assayed by testing samples spiked with appropriate concentration of Anti-Actin Antibody (Anti-ACTIN) and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.

Sample 1:2 1:4 1:8 1:16
serum(n=5) 80-99% 86-93% 83-91% 88-102%
EDTA plasma(n=5) 80-93% 92-102% 93-101% 82-91%
heparin plasma(n=5) 92-102% 80-103% 93-101% 96-103%

Stability

The stability of kit is determined by the loss rate of activity. The loss rate of this kit is less than 5% within the expiration date under appropriate storage condition.
To minimize extra influence on the performance, operation procedures and lab conditions, especially room temperature, air humidity, incubator temperature should be strictly controlled. It is also strongly suggested that the whole assay is performed by the same operator from the beginning to the end.

Reagents and materials provided

Reagents Quantity Reagents Quantity
Pre-coated, ready to use 96-well strip plate 1 Plate sealer for 96 wells 4
Standard 2 Standard Diluent 1×20mL
Detection Reagent A 1×120µL Assay Diluent A 1×12mL
TMB Substrate 1×9mL Stop Solution 1×6mL
Wash Buffer (30 × concentrate) 1×20mL Instruction manual 1

Assay procedure summary

1. Prepare all reagents, samples and standards;
2. Add 100µL standard or sample to each well. Incubate 1 hours at 37°C;
3. Aspirate and add 100µL prepared Detection Reagent A. Incubate 1 hour at 37°C;
4. Aspirate and wash 5 times;
5. Add 90µL Substrate Solution. Incubate 10-20 minutes at 37°C;
6. Add 50µL Stop Solution. Read at 450nm immediately.

ELISA Kit for Anti-Actin Antibody (Anti-ACTIN)

Test principle

The microtiter plate provided in this kit has been pre-coated with an antigen. Standards or samples are then added to the appropriate microtiter plate wells with a Horseradish Peroxidase (HRP)-conjugated secondary antibody. After TMB substrate solution is added, those wells that contain Anti-Actin Antibody (Anti-ACTIN) will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of Anti-Actin Antibody (Anti-ACTIN) in the samples is then determined by comparing the O.D. of the samples to the standard curve.

Citations

  • Influence of signaling kinases on functional dynamics of nuclear receptor CARPubmed: 31352609
  • Association of decreased triadin expression level with apoptosis of dopaminergic cells in Parkinson's disease mouse model34736417
  • Indole-linked 1, 2, 3-triazole derivatives efficiently modulate COX-2 protein levels in human THP-1 monocytes by suppressing AGE-ROS-NF-kβ nexusPubmed:34990649
  • Suppression of COX-2/PGE2 levels by carbazole-linked triazoles via modulating methylglyoxal-AGEs and glucose-AGEs–Induced ROS/NF-κB signaling in monocytesPubmed:35640822
  • Flavonoid 4, 4′-dimethoxychalcone induced ferroptosis in cancer cells by synergistically activating Keap1/Nrf2/HMOX1 pathway and inhibiting FECHPubmed:35697292

Recommend products